Moderate exercise on a regular basis may improve cancer treatments

NewsGuard 100/100 Score

Kansas State University kinesiology research offers encouraging information for cancer patients: A brisk walk or a slow jog on a regular basis may be the key to improved cancer treatments.

Brad Behnke, associate professor of exercise physiology, and collaborators have shown that moderate exercise on a regular basis enhances tumor oxygenation, which may improve treatments in cancer patients. Now Behnke is using a $750,000 American Cancer Society grant to study moderate exercise as a way to make radiation treatments more effective, especially for difficult-to-treat tumors.

"If we can increase the efficacy of radiation treatment, then the patient's prognosis is enhanced," Behnke said. "An intervention like exercise has almost universally positive side effects versus other treatments that can have deleterious side effects. Exercise is a type of therapy that benefits multiple systems in the body, and may permanently alter the environment within the tumor."

The National Cancer Institute at the National Institutes of Health recommends exercise for cancer patients and cancer survivors, but little research shows what happens within the tumors during such exercise. That prompted Behnke to combine his expertise in integrative physiology with cancer research. He also has received support from the university's Johnson Cancer Research Center.

"I became interested in finding out what happens within the tumor during and after exercise as a means to enhance treatment outcomes," Behnke said.

For the latest research, Behnke is using prostate cancer tumor models to find ways to enhance oxygen delivery to tumors. When a tumor is hypoxic, or has low oxygen, it is often very aggressive, Behnke said. Because oxygen is a "radiosensitizer," it helps destroy cancer cells. As a result, low-oxygen tumors often are resistant to traditional cancer therapies, such as radiation therapy, and interventions, such as concentrated oxygen breathing, are used to get more oxygen to the tumor before treatment.

"If we manipulate all the systems in the body -- the lungs, the heart and the blood vessels -- with exercise, we can take advantage of the dysfunctional vasculature in the tumor and enhance blood flow to the tumor," Behnke said. "The tumor becomes the path of least resistance for the elevated cardiac output of exercise, which results in a substantial increase in tumor oxygenation during and after exercise."

But the key is moderate exercise, said Behnke. Too little exercise may have no effect, but too much exercise may have a negative effect and may shut down blood flow to the tumor region or impair the immune system.

Moderate exercise is an activity that uses 30 to 60 percent of someone's aerobic capacity, Behnke said. The activity is nonstrenuous and is something that most people can perform, such as a brisk walk or a slow jog.

Research also has shown that moderate exercise can help cancer patients counteract some of the side effects of treatment -- such as low blood count, fatigue, cachexia and lost muscle mass -- which has led to many researchers labeling this as "aerobic exercise therapy" for patients with cancer, Behnke said.

"There really aren't any negative side effects of moderate-intensity exercise," Behnke said. "Exercise is often prescribed to improve the side effects of cancer and treatment, but what exercise is doing within the tumor itself is likely beneficial as well."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Lancet Commission on Breast Cancer: Transforming breast cancer care globally